Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 73413

9 recalled-product records grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
February 24, 2016
Product types
Device
Classifications
Class I
Statuses
Terminated
Recalling firm wording
Biomerieux Inc

Dossier provenance

Source snapshots represented here

  • openFDA Device Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.
  • openFDA Device Recall event_date_initiated coverage June 01, 1997–June 30, 2026

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

9 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

device · product 1 of 9

Vitek 2 Gram Positive Susceptibility Test Cards (AST-P636 REF 417951), 20 cards/kit. Product Usage: The VITEK 2 Gram Positive Susceptibility Card is intended for use with VITEK 2 Systems in clinical laboratories as an in vitro test to determine the susceptibility of Staphylococcus spp., Enterococcus spp., and S. agalactiae to antimicrobial agents when used as instructed in the Product Information manual.

Z-1639-2016
Recall number
Z-1639-2016
Initiated
February 24, 2016
Classification
Class I
Status
Terminated
Recalling firm
Biomerieux Inc
Quantity
495 kits

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Product insert fails to identify performance limitation related to EUCAST breakpoints for Teicolplanin.

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Sourced

Labeling Change Control

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

Product insert fails to identify performance limitation related to EUCAST breakpoints for Teicolplanin.

Code information

Lots 736336020 exp. 2/25/16, 736340920 exp. 4/14/16, and 736388620 exp. 8/4/17.

Distribution pattern

Foreign distribution in the countries of Czech Republic, Hong Kong (China), Hungary, Japan, Poland, South Africa, Switzerland, and Turkey.

device · product 2 of 9

Vitek 2 Gram Positive Susceptibility Test Cards (AST-P639 REF 418662), 20 cards/kit. Product Usage: The VITEK 2 Gram Positive Susceptibility Card is intended for use with VITEK 2 Systems in clinical laboratories as an in vitro test to determine the susceptibility of Staphylococcus spp., Enterococcus spp., and S. agalactiae to antimicrobial agents when used as instructed in the Product Information manual.

Z-1640-2016
Recall number
Z-1640-2016
Initiated
February 24, 2016
Classification
Class I
Status
Terminated
Recalling firm
Biomerieux Inc
Quantity
180 kits

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Product insert fails to identify performance limitation related to EUCAST breakpoints for Teicolplanin.

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Sourced

Labeling Change Control

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

Product insert fails to identify performance limitation related to EUCAST breakpoints for Teicolplanin.

Code information

Lots 739348620 exp. 6/30/16, 739348622 exp. 6/30/16, and 739348623 exp. 6/30/16.

Distribution pattern

Foreign distribution in the countries of Czech Republic, Hong Kong (China), Hungary, Japan, Poland, South Africa, Switzerland, and Turkey.

device · product 3 of 9

Vitek 2 Gram Positive Susceptibility Test Cards (AST-P640 REF 418579), 20 cards/kit. Product Usage: The VITEK 2 Gram Positive Susceptibility Card is intended for use with VITEK 2 Systems in clinical laboratories as an in vitro test to determine the susceptibility of Staphylococcus spp., Enterococcus spp., and S. agalactiae to antimicrobial agents when used as instructed in the Product Information manual.

Z-1641-2016
Recall number
Z-1641-2016
Initiated
February 24, 2016
Classification
Class I
Status
Terminated
Recalling firm
Biomerieux Inc
Quantity
7,497 kits

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Product insert fails to identify performance limitation related to EUCAST breakpoints for Teicolplanin.

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Sourced

Labeling Change Control

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

Product insert fails to identify performance limitation related to EUCAST breakpoints for Teicolplanin.

Code information

Lots 740340920 exp. 4/14/16, 740350820 exp. 7/22/16, 740356320 exp. 9/15/16, 740361110 exp. 11/2/16, 740371720 exp. 2/16/17, 740386420 exp. 7/13/17, and 740388520 exp. 8/3/17.

Distribution pattern

Foreign distribution in the countries of Czech Republic, Hong Kong (China), Hungary, Japan, Poland, South Africa, Switzerland, and Turkey.

device · product 4 of 9

Vitek 2 Gram Positive Susceptibility Test Cards (AST-P641 REF 418590), 20 cards/kit. Product Usage: The VITEK 2 Gram Positive Susceptibility Card is intended for use with VITEK 2 Systems in clinical laboratories as an in vitro test to determine the susceptibility of Staphylococcus spp., Enterococcus spp., and S. agalactiae to antimicrobial agents when used as instructed in the Product Information manual.

Z-1642-2016
Recall number
Z-1642-2016
Initiated
February 24, 2016
Classification
Class I
Status
Terminated
Recalling firm
Biomerieux Inc
Quantity
3,594 kits

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Product insert fails to identify performance limitation related to EUCAST breakpoints for Teicolplanin.

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Sourced

Labeling Change Control

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

Product insert fails to identify performance limitation related to EUCAST breakpoints for Teicolplanin.

Code information

Lots 741340920 exp. 4/14/16, 741350820 exp. 7/22/16, 741356320 exp. 9/15/16, 741357020 exp. 9/22/16, and 741366820 exp. 12/29/16.

Distribution pattern

Foreign distribution in the countries of Czech Republic, Hong Kong (China), Hungary, Japan, Poland, South Africa, Switzerland, and Turkey.

device · product 5 of 9

Vitek 2 Gram Positive Susceptibility Test Cards (AST-P642 REF 418604), 20 cards/kit. Product Usage: The VITEK 2 Gram Positive Susceptibility Card is intended for use with VITEK 2 Systems in clinical laboratories as an in vitro test to determine the susceptibility of Staphylococcus spp., Enterococcus spp., and S. agalactiae to antimicrobial agents when used as instructed in the Product Information manual.

Z-1643-2016
Recall number
Z-1643-2016
Initiated
February 24, 2016
Classification
Class I
Status
Terminated
Recalling firm
Biomerieux Inc
Quantity
15,006 kits

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Product insert fails to identify performance limitation related to EUCAST breakpoints for Teicolplanin.

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Sourced

Labeling Change Control

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

Product insert fails to identify performance limitation related to EUCAST breakpoints for Teicolplanin.

Code information

Lots 742343610 exp. 5/11/16, 742347220 exp. 6/16/16, 742350010 exp. 7/14/16, 742352820 exp. 8/11/16, 742355710 exp. 9/9/16, 742362540 exp. 11/16/16, 742364020 exp. 12/1/16, 742368210 exp. 1/12/16, 742376540 exp. 4/5/17, 742383610 exp. 6/15/17, and 742389220 exp. 8/10/17.

Distribution pattern

Foreign distribution in the countries of Czech Republic, Hong Kong (China), Hungary, Japan, Poland, South Africa, Switzerland, and Turkey.

device · product 6 of 9

Vitek 2 Gram Positive Susceptibility Test Cards (AST-P643 REF 418671), 20 cards/kit. Product Usage: The VITEK 2 Gram Positive Susceptibility Card is intended for use with VITEK 2 Systems in clinical laboratories as an in vitro test to determine the susceptibility of Staphylococcus spp., Enterococcus spp., and S. agalactiae to antimicrobial agents when used as instructed in the Product Information manual.

Z-1644-2016
Recall number
Z-1644-2016
Initiated
February 24, 2016
Classification
Class I
Status
Terminated
Recalling firm
Biomerieux Inc
Quantity
2,570 kits

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Product insert fails to identify performance limitation related to EUCAST breakpoints for Teicolplanin.

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Sourced

Labeling Change Control

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

Product insert fails to identify performance limitation related to EUCAST breakpoints for Teicolplanin.

Code information

Lots 743357720 exp. 9/29/16, 743366820 exp. 12/29/16, 743376510 exp. 4/5/17, 743380820 exp. 5/18/17, and 743387820 exp. 7/27/17.

Distribution pattern

Foreign distribution in the countries of Czech Republic, Hong Kong (China), Hungary, Japan, Poland, South Africa, Switzerland, and Turkey.

device · product 7 of 9

Vitek 2 Gram Positive Susceptibility Test Cards (AST-P644 REF 418673), 20 cards/kit. Product Usage: The VITEK 2 Gram Positive Susceptibility Card is intended for use with VITEK 2 Systems in clinical laboratories as an in vitro test to determine the susceptibility of Staphylococcus spp., Enterococcus spp., and S. agalactiae to antimicrobial agents when used as instructed in the Product Information manual.

Z-1645-2016
Recall number
Z-1645-2016
Initiated
February 24, 2016
Classification
Class I
Status
Terminated
Recalling firm
Biomerieux Inc
Quantity
5,575 kits

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Product insert fails to identify performance limitation related to EUCAST breakpoints for Teicolplanin.

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Sourced

Labeling Change Control

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

Product insert fails to identify performance limitation related to EUCAST breakpoints for Teicolplanin.

Code information

Lots 744357740 exp. 9/29/16, 744383620 exp. 6/15/17, and 744389320 exp. 8/11/17.

Distribution pattern

Foreign distribution in the countries of Czech Republic, Hong Kong (China), Hungary, Japan, Poland, South Africa, Switzerland, and Turkey.

device · product 8 of 9

Vitek 2 Gram Positive Susceptibility Test Cards (AST-P645 REF 419602), 20 cards/kit. Product Usage: The VITEK 2 Gram Positive Susceptibility Card is intended for use with VITEK 2 Systems in clinical laboratories as an in vitro test to determine the susceptibility of Staphylococcus spp., Enterococcus spp., and S. agalactiae to antimicrobial agents when used as instructed in the Product Information manual.

Z-1646-2016
Recall number
Z-1646-2016
Initiated
February 24, 2016
Classification
Class I
Status
Terminated
Recalling firm
Biomerieux Inc
Quantity
1,524 kits

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Product insert fails to identify performance limitation related to EUCAST breakpoints for Teicolplanin.

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Sourced

Labeling Change Control

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

Product insert fails to identify performance limitation related to EUCAST breakpoints for Teicolplanin.

Code information

Lots 745363420 exp. 11/25/16 and 745375920 exp. 3/30/17.

Distribution pattern

Foreign distribution in the countries of Czech Republic, Hong Kong (China), Hungary, Japan, Poland, South Africa, Switzerland, and Turkey.

device · product 9 of 9

Vitek 2 Gram Positive Susceptibility Test Cards (AST-P646 REF 420144), 20 cards/kit. Product Usage: The VITEK 2 Gram Positive Susceptibility Card is intended for use with VITEK 2 Systems in clinical laboratories as an in vitro test to determine the susceptibility of Staphylococcus spp., Enterococcus spp., and S. agalactiae to antimicrobial agents when used as instructed in the Product Information manual.

Z-1647-2016
Recall number
Z-1647-2016
Initiated
February 24, 2016
Classification
Class I
Status
Terminated
Recalling firm
Biomerieux Inc
Quantity
1,035 kits

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Product insert fails to identify performance limitation related to EUCAST breakpoints for Teicolplanin.

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Sourced

Labeling Change Control

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

Product insert fails to identify performance limitation related to EUCAST breakpoints for Teicolplanin.

Code information

Lots 746382820 exp. 6/7/17 and 746386520 exp. 7/14/17 .

Distribution pattern

Foreign distribution in the countries of Czech Republic, Hong Kong (China), Hungary, Japan, Poland, South Africa, Switzerland, and Turkey.

Field note

Send feedback

We'll only use this to respond to your feedback.